Epstein Secrets

o the Wall Street Journal (11/15, Subscription Publication, 7.57M), it is now unclear who will take over the presidency, but Merino, Reuters (11/15, Aquino) reports, "asked his Cabinet to remain in place to assist in the transition." To the AP (11/15, Bricefio, Armario), Merino's resignation plunged Pe

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

o the Wall Street Journal (11/15, Subscription Publication, 7.57M), it is now unclear who will take over the presidency, but Merino, Reuters (11/15, Aquino) reports, "asked his Cabinet to remain in place to assist in the transition." To the AP (11/15, Bricefio, Armario), Merino's resignation plunged Pe

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

o the Wall Street Journal (11/15, Subscription Publication, 7.57M), it is now unclear who will take over the presidency, but Merino, Reuters (11/15, Aquino) reports, "asked his Cabinet to remain in place to assist in the transition." To the AP (11/15, Bricetio, Armario), Merino's resignation plunged Pe

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying